After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen
By MARI YAMAGUCHI Associated Press TOKYO (AP) — Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies. It’s the first drug for the treatment of the disease in a country with a rapidly aging population. Leqembi was developed by Japanese drugmaker Eisai and
Continue Reading